SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
View ORCID ProfileZachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, Eric Hurwitz, Jeremy Coyle, Junming (Seraphina) Shi, View ORCID ProfileAndrew Mertens, Mark J. van der Laan, John M. Colford Jr., Rena C. Patel, View ORCID ProfileAlan E. Hubbard, the National COVID Cohort Collaborative (N3C) Consortium
doi: https://doi.org/10.1101/2024.02.05.24302352
Zachary Butzin-Dozier
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Yunwen Ji
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Sarang Deshpande
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Eric Hurwitz
2University of Colorado Anschutz Medical Campus, Aurora, CO USA
Jeremy Coyle
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Junming (Seraphina) Shi
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Andrew Mertens
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Mark J. van der Laan
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
John M. Colford Jr.
1School of Public Health, University of California, Berkeley, Berkeley, CA USA
Rena C. Patel
3University of Alabama at Birmingham, Birmingham, AL USA
Alan E. Hubbard
1School of Public Health, University of California, Berkeley, Berkeley, CA USA

Data Availability
All data in the present study are available upon request from the National COVID Cohort Collaborative (N3C).
Posted February 06, 2024.
SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
Zachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, Eric Hurwitz, Jeremy Coyle, Junming (Seraphina) Shi, Andrew Mertens, Mark J. van der Laan, John M. Colford Jr., Rena C. Patel, Alan E. Hubbard, the National COVID Cohort Collaborative (N3C) Consortium
medRxiv 2024.02.05.24302352; doi: https://doi.org/10.1101/2024.02.05.24302352
SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
Zachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, Eric Hurwitz, Jeremy Coyle, Junming (Seraphina) Shi, Andrew Mertens, Mark J. van der Laan, John M. Colford Jr., Rena C. Patel, Alan E. Hubbard, the National COVID Cohort Collaborative (N3C) Consortium
medRxiv 2024.02.05.24302352; doi: https://doi.org/10.1101/2024.02.05.24302352
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)